Fennec Pharmaceuticals Inc. (FENC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 7.12 |
| Open | 7.03 |
| Bid | 6.99 x 100 |
| Ask | 7.07 x 200 |
| Day's Range | 6.70 - 7.09 |
| 52 Week Range | 6.30 - 11.92 |
| Volume | |
| Avg. Volume | 161,861 |
| Market Cap | 192.313M |
| Beta (5Y Monthly) | 0.46 |
| PE Ratio (TTM) | 176.00 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) largest shareholders are individual investors who were rewarded as market cap surged US$25m last week
Key Insights The considerable ownership by individual investors in Fennec Pharmaceuticals indicates that they...
- Simply Wall St.
Those who invested in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago are up 136%
When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...
- GuruFocus.com
Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)
Fennec Pharmaceuticals Inc (NASDAQ:FENC), a biopharmaceutical company focused on the development of PEDMARK for the prevention of platinum-induced ototoxicity in pediatric cancer patients, has reported a significant insider sell transaction.
© 2024 Yahoo. All rights reserved.